These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 9039539)
1. Parenteral ganciclovir treatment of acute CMV infection in the immunocompetent host. Laing RB; Dykhuizen RS; Smith CC; Molyneaux PJ Infection; 1997; 25(1):44-6. PubMed ID: 9039539 [TBL] [Abstract][Full Text] [Related]
2. Ganciclovir treatment of systemic cytomegalovirus in an immunocompetent host. Leman JS; Toalson TW; Wlodaver CG J Okla State Med Assoc; 1997; 90(7):367-9. PubMed ID: 9379249 [TBL] [Abstract][Full Text] [Related]
3. Severe cytomegalovirus hepatitis in a pregnant woman treated with ganciclovir. Miguelez M; Gonzalez A; Perez F Scand J Infect Dis; 1998; 30(3):304-5. PubMed ID: 9790142 [TBL] [Abstract][Full Text] [Related]
4. Ganciclovir therapy for cytomegalovirus-associated liver disease in immunocompetent or immunocompromised children. Nigro G; Krzysztofiak A; Bartmann U; Clerico A; Properzi E; Valia S; Castello M Arch Virol; 1997; 142(3):573-80. PubMed ID: 9349303 [TBL] [Abstract][Full Text] [Related]
5. Ganciclovir for severe cytomegalovirus primary infection in an immunocompetent child. Hadaya K; Kaiser L; Rubbia-Brandt L; Gervaix A; Diana A Eur J Clin Microbiol Infect Dis; 2004 Mar; 23(3):218-20. PubMed ID: 14767679 [TBL] [Abstract][Full Text] [Related]
6. Acute cholestatic hepatitis by cytomegalovirus in an immunocompetent patient resolved with ganciclovir. Serna-Higuera C; González-García M; Milicua JM; Muñoz V J Clin Gastroenterol; 1999 Oct; 29(3):276-7. PubMed ID: 10509956 [TBL] [Abstract][Full Text] [Related]
7. Ganciclovir therapy in an immunocompetent child with resistant fever and hepatosplenomegaly due to cytomegalovirus infection. Who and when to treat? Tezer H; Devrim I; Kara A; Cengiz AB; Seçmeer G Int J Infect Dis; 2008 May; 12(3):340-2. PubMed ID: 18023387 [No Abstract] [Full Text] [Related]
8. Cytomegalovirus infection in immunocompetent wheezy infants: the diagnostic value of CMV PCR in bronchoalveolar lavage fluid. Cinel G; Pekcan S; Ozçelik U; Alp A; Yalçın E; Doğru Ersöz D; Kiper N J Clin Pharm Ther; 2014 Aug; 39(4):399-403. PubMed ID: 25040449 [TBL] [Abstract][Full Text] [Related]
9. [Cytomegalovirus cholestasis in an immunocompetent host]. Ouandaf A; Chergui H; Seffar M; Chocho Z; Marcil S; Ouazzani H; Kabbaj H Ann Biol Clin (Paris); 2019 Jun; 77(3):323-326. PubMed ID: 30977729 [TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus encephalitis in immunocompetent infants: A 15-year retrospective study at a single center. Guo Y; Jiang L Int J Infect Dis; 2019 May; 82():106-110. PubMed ID: 30844517 [TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus hepatitis and ganciclovir treatment in immunocompetent children. Tezer H; Seçmeer G; Kara A; Ceyhan M; Cengiz AB; Devrim I; Us D; Yüce A; Gürakan F; Yildirim I; Ozen H; Saltik-Temizel IN Turk J Pediatr; 2008; 50(3):228-34. PubMed ID: 18773667 [TBL] [Abstract][Full Text] [Related]
12. Disseminated cytomegalovirus infection in an immunocompetent adult successfully treated with ganciclovir. López-Contreras J; Ris J; Domingo P; Puig M; Rabella N; Nolla J Scand J Infect Dis; 1995; 27(5):523-5. PubMed ID: 8588148 [TBL] [Abstract][Full Text] [Related]
13. Ganciclovir therapy in cytomegalovirus (CMV) infection in immunocompetent pediatric patients. Avila-Agüero ML; Paris MM; Alfaro W; Avila-Agüero CR; Faingezicht I Int J Infect Dis; 2003 Dec; 7(4):278-81. PubMed ID: 14656419 [TBL] [Abstract][Full Text] [Related]
14. Ganciclovir therapy in two immunocompetent infants with severe acquired CMV pneumonitis. Suresh N; Thiruvengadam V Paediatr Int Child Health; 2013 Feb; 33(1):46-8. PubMed ID: 23485496 [TBL] [Abstract][Full Text] [Related]
15. Human cytomegalovirus pneumonia in an immunocompetent patient: a very uncommon but treatable condition. Waqas QA; Abdullah HMA; Khan UI; Oliver T BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31451465 [TBL] [Abstract][Full Text] [Related]
16. Ganciclovir therapy for severe cytomegalovirus infection in immunocompetent patients. Jacobson MA Clin Infect Dis; 1997 Dec; 25(6):1487-8. PubMed ID: 9431412 [No Abstract] [Full Text] [Related]
17. Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation. Montesinos P; Sanz J; Cantero S; Lorenzo I; Martín G; Saavedra S; Palau J; Romero M; Montava A; Senent L; Martínez J; Jarque I; Salavert M; Córdoba J; Gómez L; Weiss S; Moscardó F; de la Rubia J; Larrea L; Sanz MA; Sanz GF Biol Blood Marrow Transplant; 2009 Jun; 15(6):730-40. PubMed ID: 19450758 [TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal CMV in an elderly, immunocompetent patient. Fyock C; Gaitanis M; Gao J; Resnick M; Shah S R I Med J (2013); 2014 Jun; 97(6):53-6. PubMed ID: 24905377 [TBL] [Abstract][Full Text] [Related]
19. Reactivation versus primary CMV infection after splenectomy in immunocompetent patients. Assy N; Gefen H; Schlesinger S; Karim W Dig Dis Sci; 2007 Dec; 52(12):3477-9. PubMed ID: 17431778 [TBL] [Abstract][Full Text] [Related]
20. Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. Noble S; Faulds D Drugs; 1998 Jul; 56(1):115-46. PubMed ID: 9664203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]